Trademark: 97020058
Word
INHIBINOL
Status Date
Monday, July 22, 2024
Filing Date
Thursday, September 9, 2021
Published for Opposition
Tuesday, April 26, 2022
Abandoned Date
Monday, July 22, 2024
5 Nutraceuticals for use as a dietary supplement; pharmaceutical preparations for the treatment of COVID-19, colds and flu, coronavirus disease, cardiovascular diseases and disorders, respiratory infections, eye infections, and respiratory diseases and disorders; anti-inflammatory preparations; anti-inflammatories; nutraceuticals for the treatment of respiratory and dietary diseases; antivirals for treatment or prevention of COVID-19, coronavirus disease, and respiratory diseases and disorders; botanicals extracts for the treatment of colds and flu; cardiovascular nutraceutical preparations; herbal supplements for the treatment of the respiratory system; nutraceuticals for regulating the immune system; nutraceuticals for the treatment of infectious diseases, namely, respiratory infections, eye infections; nutraceuticals for the treatment of respiratory diseases, disorders and infections; nutraceuticals for the treatment of the respiratory system; nutraceuticals for treatment or prevention of COVID-19, coronavirus disease, and respiratory diseases and disorders; nutraceuticals for treating respiratory diseases; nutraceuticals for the treatment of coronavirus diseases and COVID-19; vitamin and mineral preparations for medical use
1 Vitamins for use in the manufacture of nutraceuticals
42 Development of pharmaceutical preparations, nutraceuticals, and medicines; pharmaceutical and nutraceutical product development services; research and development of new products for others; drug and nutraceutical product discovery services in the nature of product research; AI-driven development of pharmaceutical preparations, nutraceuticals, and medicines; research and development of pharmaceuticals; conducting early evaluations in the field of new pharmaceuticals; pharmaceutical and nutraceutical product evaluation
Sep 13, 2021
New Application Entered
Oct 19, 2021
New Application Office Supplied Data Entered
Mar 9, 2022
Assigned To Examiner
Mar 15, 2022
Examiners Amendment -Written
Mar 15, 2022
Examiners Amendment E-Mailed
Mar 15, 2022
Notification Of Examiners Amendment E-Mailed
Mar 15, 2022
Examiner's Amendment Entered
Mar 15, 2022
Approved For Pub - Principal Register
Mar 21, 2022
Assigned To Lie
Mar 24, 2022
Law Office Publication Review Completed
Apr 6, 2022
Notification Of Notice Of Publication E-Mailed
Apr 26, 2022
Published For Opposition
Apr 26, 2022
Official Gazette Publication Confirmation E-Mailed
Jun 21, 2022
Noa E-Mailed - Sou Required From Applicant
Oct 4, 2022
Teas Revoke/App/Change Addr Of Atty/Dom Rep Received
Oct 4, 2022
Attorney/Dom.Rep.Revoked And/Or Appointed
Oct 4, 2022
Teas Change Of Correspondence Received
Dec 15, 2022
Sou Teas Extension Received
Dec 15, 2022
Sou Extension 1 Filed
Dec 15, 2022
Sou Extension 1 Granted
Dec 17, 2022
Notice Of Approval Of Extension Request E-Mailed
Apr 26, 2023
Automatic Update Of Assignment Of Ownership
Jun 19, 2023
Sou Teas Extension Received
Jun 19, 2023
Sou Extension 2 Filed
Jun 19, 2023
Sou Extension 2 Granted
Jun 21, 2023
Notice Of Approval Of Extension Request E-Mailed
Dec 14, 2023
Sou Extension 3 Granted
Dec 14, 2023
Sou Teas Extension Received
Dec 14, 2023
Sou Extension 3 Filed
Jul 22, 2024
Abandonment - No Use Statement Filed
Jul 22, 2024
Abandonment Notice E-Mailed - No Use Statement Filed
Dec 16, 2023
Notice Of Approval Of Extension Request E-Mailed
Trademark Alertz updated from USPTO on 2030-01-24
